Natasha Leskovsek

Of Counsel
Full contact info

I’ve taken my clinical and consulting experience for pharma and biotech companies on regulatory issues and brought them to Cooley’s clients.

Passions

Providing practical compliance solutions at the intersection of science and regulation

Experience

Radionetics Oncology Announces Strategic Agreement With Eli Lilly

July 1, 2024

Cooley advised Radionetics Oncology, a biotechnology company discovering and developing novel small molecule G protein-coupled receptor (GPCR)-targeted radiopharmaceuticals to treat a broad range of solid tumors, on the formation of a strategic agreement with Eli Lilly to take forward Radionetics’ proprietary GPCR-targeting small molecule radiopharmaceuticals. Under the terms of the agreement, Radionetics received a $140 million up-front cash payment. Additionally, Lilly obtained the exclusive right to acquire Radionetics for $1 billion upon conclusion of an exercise period.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Charity Williams
Partner, San Diego
Jenny Ge
Associate, Los Angeles Santa Monica
Chen Chen
Associate, Palo Alto
Todd Gluth
Partner, San Diego
Alessandra Murata
Partner, Palo Alto
Ross Eberly
Partner, Los Angeles Santa Monica
Howard Morse
Partner, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
David Burns
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Karen Tsai
Special Counsel, Washington, DC
Ajay Athavale
Associate, San Francisco
Jonathan Kaufman
Associate, Palo Alto
Allison Kutner
Associate, New York
Edmond Lay
Associate, San Diego
Jeremy Gentile
Associate, San Diego
Amanda Pacheco
Associate, Palo Alto
Breanna Qin
Associate, Palo Alto
Megan Drill
Associate, San Diego
Daniel Gillon
Associate, San Diego
Jack Whitaker
Associate, San Diego
Patricia Myers
Paralegal Specialist, Colorado

Related Practices & Industries

Perceptive Advisors Enters Into Definitive Merger Agreement With Vapotherm

June 17, 2024

Cooley advised Perceptive Advisors, a top healthcare investment firm, and its affiliates, including Perceptive Discovery Fund, on its definitive merger agreement with Vapotherm, a publicly traded developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, and listed as VAPO on the over-the-counter quotation exchange (OTCQX).

Read more

Related contacts

Amelia Runyan Davis
Partner, Colorado
Tessa W Bell
Associate, Colorado
Rachel Shapiro
Associate, Colorado
Kevin Cooper
Partner, New York
Natalie D. Vernon
Associate, Colorado
Matan Neuman
Associate, New York
Eric Blanchard
Partner, Boston
Jean Park
Partner, New York
Yoon Soo (Peter) Shin
Associate, New York
Patricia Myers
Paralegal Specialist, Colorado
Megan Browdie
Partner, Washington, DC
Thomas Connors
Partner, Boston
Patrick Flanagan
Partner, New York
Adam Fleisher
Partner, Washington, DC
David Fletcher
Partner, Washington, DC
Steve Flores
Partner, Chicago
Annie Froehlich
Partner, Washington, DC
Stephanie Gentile
Partner, New York
Phil Mitchell
Partner, New York
Miriam Petrillo
Partner, Chicago
Scott Weston
Partner, Boston
Aric Wu
Partner, New York
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Sharon Connaughton
Special Counsel, Washington, DC
Christine Graham
Special Counsel, London
Reid Hooper
Special Counsel, Washington, DC
Ryan Montgomery
Special Counsel, Boston
Grant Schweikert
Special Counsel, Washington, DC
Jennifer Shanley
Special Counsel, New York
Julie Wicklund
Special Counsel, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
Karun Ahuja
Associate, Chicago
Anna Caro
Associate, London
Paula Fleckenstein
Associate, Reston
Jimmy Gilligan
Associate, Boston
Rick Jantz
Associate, Los Angeles Santa Monica
Alexandra Leavy
Associate, New York
Rubin Waranch
Associate, Colorado
John Masters
Patent Agent, Chicago

Related Practices & Industries

Structure Therapeutics Announces Upsized $547.4 Million Public Offering

June 7, 2024

Cooley advised Structure Therapeutics (Nasdaq: GPCR), a global, clinical-stage biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases, on its upsized $547.4 million underwritten public offering.

Related contacts

Patrick Loofbourrow
Partner, Singapore
Charlie Kim
Partner, San Diego
Jean Park
Partner, New York
Carlos Ramirez
Partner, San Diego
Su Lian Lu
Special Counsel, Los Angeles Santa Monica
Christine Turner
Associate, Colorado
Christine S. Kim
Associate, San Diego
Daniel Gillon
Associate, San Diego
Max Levinbook
Associate, San Diego
Alexis Guillermo Buz
Associate, San Diego
Reid Hooper
Special Counsel, Washington, DC
Rick Jantz
Associate, Los Angeles Santa Monica
Brian Lau
International Legal Project Manager, Hong Kong
Xander Lee
Partner, Los Angeles Santa Monica
Natasha Leskovsek
Of Counsel, Washington, DC
Phil Mitchell
Partner, New York
Aaron Pomeroy
Partner, Colorado
Rebecca Ross
Special Counsel, Washington, DC
Vince Sampson
Special Counsel, Washington, DC
Jennifer Shanley
Special Counsel, New York
Karen Tsai
Special Counsel, Washington, DC
Jessica Wade
Paralegal Specialist, San Diego
Kate Walther
Paralegal Specialist, San Diego
Francis Wheeler
Partner, Colorado

Related Practices & Industries

Tenet Medicines to Be Acquired by Eliem Therapeutics

April 11, 2024

Cooley advised Tenet Medicines, a development-stage private biotechnology company, on its definitive agreement to be acquired by Eliem Therapeutics, a biotech company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems.

Read more

Related contacts

Elizabeth Galvin
Associate, Boston
Miguel J. Vega
Partner, Boston
Eric Blanchard
Partner, Boston
Ryan Sansom
Partner, Boston
Mike Nelson
Partner, Colorado
Kurtis Zinger
Associate, Colorado
Margaux Arntson
Associate
Stephanie Gentile
Partner, New York
Ryan Montgomery
Special Counsel, Boston
Megan Browdie
Partner, Washington, DC
Phil Mitchell
Partner, New York
Geoffrey Spolyar
Partner, Boston
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
Trevor Bossi
Associate, Boston
Wyatt Kernell
Associate, Colorado
Nicollette R. Kirby
Associate, Washington, DC
Amanda Pacheco
Associate, Palo Alto
Amanda Pacheco
Associate, Palo Alto
Eric Schmid
Associate, Boston
Steven A. Zuckerman
Associate, New York
Stacy Colter
Senior Paralegal, Colorado
Patricia Myers
Paralegal Specialist, Colorado

Related Practices & Industries

Adaptive Phage Therapeutics Enters Into Definitive Merger Agreement With BiomX

March 6, 2024

Cooley advised Adaptive Phage Therapeutics, a US-based, privately held, clinical-stage biotechnology company pioneering the development of phage-based therapies to combat bacterial infections, on its definitive merger agreement with BiomX, a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria.

Read more

Related contacts

Christian Plaza
Partner, Reston
Matthew D. Silverman
Special Counsel, Los Angeles Santa Monica
Brian Leaf
Partner, Reston
Matthew Schwee
Partner, Reston
Joyce Li
Associate, Chicago
Rasha Printz
Associate, Reston
John Lavoie
Partner in Charge – Reston, Reston
Kenneth Krisko
Partner, Reston
Eileen Marshall
Partner, Washington, DC
Phil Mitchell
Partner, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Adrienne Beaudoin Deshmukh
Associate, Reston
Rick Jantz
Associate, Los Angeles Santa Monica
Anne Luquette
Associate, San Francisco
Tyler McClure
Associate, San Francisco
Patricia Myers
Paralegal Specialist, Colorado
Douglas Lyles
Senior Research Services & Access Analyst
View more

Admissions and credentials

District of Columbia

Maryland

Memberships and affiliations

Food and Drug Law Institute